CIMT measurement |
VEIS Update
Detecting and treating the vascular problems for better quality of life
Wednesday, December 12, 2012
Effect of parental smoking on children?
Tuesday, December 4, 2012
Lipodermatosclerosis and chronic venous disease
Patients
with chronic venous disease (venous insufficiency) develop changes in the foot,
ankle and leg. They develop varying degrees of varicose veins, skin
pigmentation, thickening of the skin and subcutaneous tissues and ulceration in
the ankle region. Skin thickening and
nodular formation mimics cellulitis in many patients and there is a possibility
that many of them may receive antibiotics for control infection and cellulitis.
The thickening of the skin and subcutaneous tissues in chronic venous disease
usually occurs on the medial side of the leg. Skin pigmentation is common and
it is rare to see the induration and thickening on the medial side without skin
pigmentation. It is still not clear which factors will
determine the development of the thickness of the tissues ( Lipodermatosclerosis)
and the speed at which they develop in a given patient. We have seen this symptom
Lipodermatosclerosis in people who are obese and non-obese, who are tall and
short. It may not be uncommon to see a obese man with inverted champagne bottle
like legs in vascular surgery clinics. The indurated, sclerotic plaques with a
“bound-down” appearance (ie, they appear as if tethered—or bound—to the
subcutaneous tissue) affecting the skin from below the knee to the ankle is
common in our clinics in patients who had chronic venous disease for more than
10 years with or without history of DVT. Usually there is a sharp demarcation
between affected and unaffected skin. It
is proposed that venous reflux leads to increased venous pressures which can
result in extravasation of interstitial fluid and red blood cells, decreased
diffusion of oxygen to the tissues, and eventual tissue and endothelial damage.
As the endothelium is damaged, microthrombi formation and infarction ensue,
stimulating fibroblasts to form granulation tissue. Fibroblast might be playing a major role in
progression of the fibrotic reaction in the ankle and leg region. The dilated veins
are palpable in this scar like tissues and sometimes they may be source of
profuse bleed from the ankle region. When such a bleed occurs one would be concerned
about further bleeds from the leg. Sclerotherapy may help to stop the bleed and
heal ulcers. But patients would certainly like to get it excised completely and
get skin grafting if possible.
Monday, October 17, 2011
Effect of Injuries in patients receiving warfarin
Injuries in patients who are on oral anticoagulants
and antiplatelet drugs
In
the recent past increasing number of cardiovascular patients (atrial
fibrillation, DVT, post interventions) are put on oral anticoagulants and
antiplatelet drugs after a life or limb threatening cardiovascular event. Therapeutic advancements are increasing probably
the need for these special classes of drugs in our patients. We are concerned
about the risk of bleeding in such patients.
Spontaneous bleeding is one and prolonged and profuse bleeding from
trauma is the other which we may have address in some of these patients. We
have already noted the increased risk of puncture site complications (bleeding,
pseudo-aneurysm) after angiogram or angioplasty in those receiving the triple
antiplatelet therapy in the cardiac patients.
The patients are leading active lives and traveling like any person
after recovering from cardiovascular events and there is a probability that
they may be prone for injuries.
If
a patient who is on oral anticoagulants or antiplatelet drugs sustain injuries
there can be more bleeding and some times it can be life threatening. Bleeding
in to the closed cavities such as intracranial, intra thoracic and
retroperitoneal can continue for longer periods under the influence of the
drugs. Recently DJ Bonville et al from
Albany retrospectively reviewed (3,436) the impact of pre-injury warfarin and
antiplatelet drugs (456) on the outcomes of trauma patients from 2004 – 2007 at
a New York state level-1 trauma center.
Patients on Warfarin were 3.1 times more likely die after adjusting for
potential confounders. Aspirin and clopidogrel were not associated with
increased mortality. But these drugs were associated with increased risk of
Intra cranial hemorrhage (ICH). But
among the ICH patients increased mortality was associated with warfarin. (Surgery
2011;150: 861-8)
In
many countries and in India the aging population is going increase in the
coming years. In USA people above 65 years are 13% and they are going to become
20% in 2050. Some of these are going to
receive these medications. Many studies
in the past linked the mortality and morbidity of trauma patients to the use of
anticoagulants. In one retrospective study Dossett et al reviewed one million trauma patients
admitted in 402 centers. In this group 36,270 patients were taking warfarin. Among these taking warfarin 9.3% died and
only 4.3% died in the group not taking warfarin. (Arch Surg 2011;146:565-70).
Initiation
of oral anticoagulation after giving heparin for 5 days in DVT patients is
practiced in many hospitals. The tablet warfarin action is monitored by testing
the INR frequently and maintained between 2-3. It is difficult for the patients
who are not living close to the towns to get the reliable INR tests. The Indian
diet may be also interfering with action of the drugs. Anticoagulation clinics
are not present in states like Andhra Pradesh in India. There is a need for the
development of web sites to guide these patients about the drug interactions
and precautions to be taken while taking the medication. It will be very
convenient for the patients if is possible to provide the free testing
facilities at the pharmacies supplying (selling) the medications. These
patients can carry a card which can be flashed in case of emergency such as
trauma to help the treating doctors to take necessary precautions and reverse
the effects of anticoagulation (warfarin effect). Correction with Fresh frozen
plasma, Injection Vitamin K and Factor
VIIa are used for reversing the warfarin effect.
Saturday, October 8, 2011
De-branching of aorta during Aortic Aneurysm repair
Even though it was introduced more than 5 decades back open surgical aortic aneurysm repair is still considered to be a major surgery associated with morbidity and mortality. Aneurysms of the aorta are repaired only in few centers in the state Andhrapradesh. Therefore it is not a popular operation and it is also associated with an expenditure which is unpredictable due to the perioperative and postoperative events. The common man who is generally dependent on the Govt health services. But very few government hospitals are providing the aneurysmsal surgery services through the cardiothoracic surgery departments. The new health care scheme "Aarogyasri" is covering the aortic aneurysm repair but the reimbursement is limited and so, the providers in the hospitals are hesitant to ask their treating doctors to take up such cases. In the past many complex aortic aneurysms engulfing the important branches were considered to be inoperable or associated with high morbidity. But endovascular repair with debranching of the aorta is making it possible to treat these patients with less morbidity and more predictability of outcomes.
There is a loud rethinking in the west that this type of two stage procedures (debranching and endorepair) can save the patients from morbidity and mortality. But the cost of such procedures still continues to be high and in few institutions in India it is exorbitantly high. The Aarogyasri scheme is currently not recognizing and covering such therapies. It would be better and helpful to the patients if the health insurances companies enquire about such procedures and approve few hospitals to provide such therapies to benefit the people who are in need of such treatments.
There is a loud rethinking in the west that this type of two stage procedures (debranching and endorepair) can save the patients from morbidity and mortality. But the cost of such procedures still continues to be high and in few institutions in India it is exorbitantly high. The Aarogyasri scheme is currently not recognizing and covering such therapies. It would be better and helpful to the patients if the health insurances companies enquire about such procedures and approve few hospitals to provide such therapies to benefit the people who are in need of such treatments.
Subscribe to:
Posts (Atom)